SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 9, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-11
DOI
10.1038/s41419-019-1884-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic therapies inhibit tumor growth in vivo and in silico
- (2019) Jorgelindo da Veiga Moreira et al. Scientific Reports
- Thymidine phosphorylase promotes malignant progression in hepatocellular carcinoma through pentose Warburg effect
- (2019) Qiang Zhang et al. Cell Death & Disease
- Properties of FDA-approved small molecule protein kinase inhibitors
- (2019) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Expedient Synthesis of Alphitolic Acid and Its Naturally Occurring 2-O-Ester Derivatives
- (2019) Somin Park et al. JOURNAL OF NATURAL PRODUCTS
- The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
- (2019) Xing Huang et al. Autophagy
- PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling
- (2019) Zhongyi Fan et al. CANCER LETTERS
- Metabolic reprogramming links chronic intestinal inflammation and the oncogenic transformation in colorectal tumorigenesis
- (2019) Sha Zhang et al. CANCER LETTERS
- Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo
- (2019) Ling Wei et al. PHARMACOLOGICAL RESEARCH
- Hepatitis B virus DNA levels and overall survival in hepatitis B‐related hepatocellular carcinoma patients with low‐level viremia
- (2019) Tae‐Se Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- MiRNA-124 inhibits the proliferation, migration and invasion of cancer cell in hepatocellular carcinoma by downregulating lncRNA-UCA1
- (2019) Baolei Zhao et al. OncoTargets and Therapy
- Identification and functional characterization of Lys-trimethylation of lactate dehydrogenase A
- (2019) Lin Li et al. OncoTargets and Therapy
- ARHGAP4 mediates the Warburg effect in pancreatic cancer through the mTOR and HIF-1α signaling pathways
- (2019) Yehua Shen et al. OncoTargets and Therapy
- Transcriptional activation of SIRT6 via FKHRL1/FOXO3a inhibits the Warburg effect in glioblastoma cells
- (2019) Zhen Dong et al. CELLULAR SIGNALLING
- Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721 cell proliferation, vasculogenic mimicry, and radioresistance
- (2019) Wei Yang et al. CELLULAR SIGNALLING
- Hepatitis B X protein upregulates decoy receptor 3 expression via the PI3K/NF-κB pathway
- (2019) Dong-Yu Liang et al. CELLULAR SIGNALLING
- Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma
- (2018) Fan Feng et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Betulin inhibits lipopolysaccharide/D-galactosamine-induced acute liver injury in mice through activating PPAR-γ
- (2018) Guang-men Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- The ameliorative effect of Homalium nepalense on carbon tetrachloride-induced hepatocellular injury in rats
- (2018) Satish Kanhar et al. BIOMEDICINE & PHARMACOTHERAPY
- Transcriptional Regulation of the Warburg Effect in Cancer by SIX1
- (2018) Ling Li et al. CANCER CELL
- p66Shc regulates migration of castration-resistant prostate cancer cells
- (2018) Matthew A. Ingersoll et al. CELLULAR SIGNALLING
- AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis
- (2018) Bin Zheng et al. CELLULAR SIGNALLING
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis
- (2018) Fan Feng et al. PHARMACOLOGICAL RESEARCH
- MiR-3662 suppresses hepatocellular carcinoma growth through inhibition of HIF-1α-mediated Warburg effect
- (2018) Zhiqiang Chen et al. Cell Death & Disease
- Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
- (2018) Yingshi Zhang et al. Cell Death & Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FOXO3a-dependent up-regulation of Mxi1-0 promotes hypoxia-induced apoptosis in endothelial cells
- (2018) Zhenzhen Hu et al. CELLULAR SIGNALLING
- Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors
- (2018) Pedro Miguel Lacal et al. PHARMACOLOGICAL RESEARCH
- ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR
- (2018) Zhiyi Shao et al. PHARMACOLOGICAL RESEARCH
- Targeting oncogenic Raf protein-serine/threonine kinases in human cancers
- (2018) Robert Roskoski PHARMACOLOGICAL RESEARCH
- MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor
- (2018) Jiaqi Li et al. OncoTargets and Therapy
- Aminophenols increase proliferation of thyroid tumor cells by inducing the transcription factor activity of estrogen receptor α
- (2018) Lin Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Combinatorial regulation of hepatic cytoplasmic signaling and nuclear transcriptional events by the OGT/REV-ERBα complex
- (2018) Alexandre Berthier et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells
- (2018) Du Meng et al. OncoTargets and Therapy
- Procaspase-3-activating compound 1 stabilizes hypoxia-inducible factor 1α and induces DNA damage by sequestering ferrous iron
- (2018) Feifei Li et al. Cell Death & Disease
- LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells
- (2018) Yan Chen et al. Cancer Management and Research
- Inhibition of the sterol regulatory element-binding protein pathway suppresses hepatocellular carcinoma by repressing inflammation in mice
- (2017) Na Li et al. HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversal
- (2017) Li An et al. PHARMACOLOGICAL RESEARCH
- The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis
- (2017) Yingchun Liang et al. Cell Death & Disease
- miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14
- (2017) Quanbo Ji et al. Cell Death & Disease
- A signature motif in LIM proteins mediates binding to checkpoint proteins and increases tumour radiosensitivity
- (2017) Xiaojie Xu et al. Nature Communications
- GP73 regulates Hepatic Steatosis by enhancing SCAP-SREBPs interaction
- (2017) Xiaoli Yang et al. Scientific Reports
- Current advances in the elimination of hepatitis B in China by 2030
- (2017) Shuye Zhang et al. Frontiers of Medicine
- Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth
- (2016) L. Liu et al. CANCER RESEARCH
- Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876
- (2016) Holger Siebeneicher et al. ChemMedChem
- Requirements for global elimination of hepatitis B: a modelling study
- (2016) Shevanthi Nayagam et al. LANCET INFECTIOUS DISEASES
- Suppression of miR-199a maturation by HuR is crucial for hypoxia-induced glycolytic switch in hepatocellular carcinoma
- (2015) L.-F. Zhang et al. EMBO JOURNAL
- MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway
- (2015) Heng Wu et al. GUT
- Warburg Effect or Reverse Warburg Effect? A Review of Cancer Metabolism
- (2015) Xiao Dong Xu et al. Oncology Research and Treatment
- Blocking Lipid Synthesis Overcomes Tumor Regrowth and Metastasis after Antiangiogenic Therapy Withdrawal
- (2014) Nor Eddine Sounni et al. Cell Metabolism
- The global burden of liver disease: The major impact of China
- (2014) Fu-Sheng Wang et al. HEPATOLOGY
- SREBP-1 Has a Prognostic Role and Contributes to Invasion and Metastasis in Human Hepatocellular Carcinoma
- (2014) Chao Li et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Free radical biology for medicine: learning from nonalcoholic fatty liver disease
- (2013) Gaetano Serviddio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques
- (2011) Jing-Jie Tang et al. Cell Metabolism
- Human Fatty Liver Disease: Old Questions and New Insights
- (2011) J. C. Cohen et al. SCIENCE
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now